The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global cannula market size reached US$ 138.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 206.6 Billion by 2027, exhibiting a CAGR of 7.4% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
A cannula is a small hollow tube with a sharp and retractable inner core that is inserted into a vein, artery or body cavity to administer medication and draw off fluids. Several types of cannula are available for performing different procedures. For instance, an intravenous cannula is used in cardiac surgery by establishing cardiopulmonary bypass. Similarly, a nasal cannula is utilized for administering oxygen by running the plastic tubing beneath the nose. Additionally, it is widely used for injecting fillers as it causes lesser pain, reduces the risk of bleeding and bruising, and provides greater flexibility as compared to hypodermic needles. Owing to its numerous attributes, it finds extensive applications in hospitals, ambulatory surgery centers (ASCs), blood banks, laboratories and pathology labs across the globe.
The rising prevalence of lifestyle diseases, such as obesity and diabetes, is increasing the number of surgical procedures being performed around the world, which, in turn, is strengthening the cannula market growth. Additionally, the growing geriatric population, along with the growing inclination toward minimally invasive surgeries (MIS), is impelling the market growth. Furthermore, the increasing influence of social media and the growing popularity of cosmetic surgeries are also positively influencing the demand for cannula. Moreover, favorable government policies for providing primary healthcare services, coupled with the increasing advancements in healthcare facilities, are further boosting the market growth. Other than this, leading vendors are investing in research and development (R&D) projects for introducing advanced products. For instance, LivaNova PLC, a medical device manufacturing company, recently launched a bidirectional arterial cannula to reduce the risk of limb ischemia.
IMARC Group provides an analysis of the key trends in each sub-segment of the global cannula market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, application, type, size, material and end user.
Breakup by Product:
Breakup by Type:
Breakup by Size:
Breakup by Material:
Breakup by Application:
Breakup by End-User:
Breakup by Region:
The competitive landscape of the industry has also been examined with some of the key players being Boston Scientific Corporation, CONMED Corporation, Edwards Lifesciences, Medtronic Plc, Smith+Nephew, Smiths Medical Inc., LivaNova Plc, Teleflex Incorporated, Terumo Corporation, etc.
|Base Year of the Analysis||2021|
|Segment Coverage||Product, Application, Type, Size, Material, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Boston Scientific Corporation, CONMED Corporation, Edwards Lifesciences, Medtronic Plc, Smith+Nephew, Smiths Medical Inc., LivaNova Plc, Teleflex Incorporated and Terumo Corporation|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
We expect the global cannula market to exhibit a CAGR of 7.4% during 2022-2027.
Sudden outbreak of the COVID-19 pandemic had led to the increase in demand for cannula across the healthcare sector to treat severely infected patients from coronavirus.
The high prevalence of numerous chronic diseases, such as cardiac arrest, cancer, respiratory disorders, etc., along with the growing number of surgical procedures, are some of the factors catalyzing the global cannula market.
Based on the product, the global cannula market has been categorized into cardiac cannulas, vascular cannulas, nasal cannulas, dermatology cannulas, arthroscopy cannulas, and others. Among these, cardiac cannulas currently hold the majority of the share in the market.
Based on the type, the global cannula market has been segmented into neonatal cannulas, winged cannulas, straight cannulas, wing with port cannulas, and others, where straight cannulas account for the majority of the total market share.
Based on the size, the global cannula market has been bifurcated into 14G, 16G, 18G, 20G, 22G, 24G, and 26G. Currently, 18G sized cannula holds the majority of the total market share.
Based on the material, the global cannula market has been divided into plastic (PVC) cannulas, silicone cannulas, and metal cannulas (stainless steel). Among these, plastic (PVC) cannulas currently represent the largest segment.
Based on the end-user, the global cannula market has been segregated into hospitals, ambulatory surgery centers (ASCs), and others. Currently, hospitals exhibit a clear dominance in the market.
On a regional level, the market has been classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America, where North America currently dominates the global market.
Some of the major players in the global cannula market include Boston Scientific Corporation, CONMED Corporation, Edwards Lifesciences, Medtronic Plc, Smith+Nephew, Smiths Medical Inc., LivaNova Plc, Teleflex Incorporated, Terumo Corporation, etc.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at